MA43415A - Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées - Google Patents

Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Info

Publication number
MA43415A
MA43415A MA043415A MA43415A MA43415A MA 43415 A MA43415 A MA 43415A MA 043415 A MA043415 A MA 043415A MA 43415 A MA43415 A MA 43415A MA 43415 A MA43415 A MA 43415A
Authority
MA
Morocco
Prior art keywords
modified rna
uridine diphosphate
rna coding
associated uses
diphosphate glucuronosyltransferase
Prior art date
Application number
MA043415A
Other languages
English (en)
Inventor
Christian Cobaugh
Melissa Lasaro
David Osterman
Haren Vasavada
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of MA43415A publication Critical patent/MA43415A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01017—Glucuronosyltransferase (2.4.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA043415A 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées MA43415A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562265174P 2015-12-09 2015-12-09

Publications (1)

Publication Number Publication Date
MA43415A true MA43415A (fr) 2018-10-17

Family

ID=57758709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043415A MA43415A (fr) 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Country Status (4)

Country Link
US (1) US20190307857A1 (fr)
EP (1) EP3386533A1 (fr)
MA (1) MA43415A (fr)
WO (1) WO2017100562A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA53615A (fr) * 2018-09-14 2021-07-21 Modernatx Inc Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar
US20240376445A1 (en) * 2021-06-22 2024-11-14 Modernatx, Inc. Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
PL2578685T3 (pl) 2005-08-23 2020-01-31 The Trustees Of The University Of Pennsylvania Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
JP5405122B2 (ja) 2005-12-21 2014-02-05 ワイス・エルエルシー 低粘度のタンパク質製剤およびその用途
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
US8853377B2 (en) 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
WO2012129648A1 (fr) 2011-03-25 2012-10-04 University Of Guelph Activation d'expression de protéines de vecteurs de virus adéno-associés
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
WO2013151664A1 (fr) 2012-04-02 2013-10-10 modeRNA Therapeutics Polynucléotides modifiés pour la production de protéines
CN104411338A (zh) * 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
EA201492055A1 (ru) 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
ES2744565T3 (es) * 2014-04-25 2020-02-25 Genethon Tratamiento de la hiperbilirrubinemia

Also Published As

Publication number Publication date
WO2017100562A9 (fr) 2017-08-03
EP3386533A1 (fr) 2018-10-17
US20190307857A1 (en) 2019-10-10
WO2017100562A1 (fr) 2017-06-15

Similar Documents

Publication Publication Date Title
MA49634A (fr) Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées
EP3690044C0 (fr) Ingénierie génomique multiplexe validée ayant recours au système crispr
GB201715242D0 (en) Waveguide modulator structures
HUE056911T2 (hu) Genetikai konstrukció
EP3307158A4 (fr) Bolus pour veau
EP3695073A4 (fr) Dispositif d'espacement de dalles
EP3317390A4 (fr) Tensio-actifs anioniques
SMT201900699T1 (it) Copertura di cemento
PL4030014T3 (pl) Wkładka dystansowa ścienna
FR3029231B1 (fr) Section en beton
DK3296597T3 (da) Krydshovedmotor
SG11201708196PA (en) Piling construction management method
EP3362929A4 (fr) Néoépitopes viraux et utilisations de ces derniers
EP3268200A4 (fr) Démoulage à faible délaminage
MA49684A (fr) Arnm modifié codant une glucose-6-phosphatase et utilisations associées
EP3338115A4 (fr) Simulations de réservoir incluant des réseaux de fracture
ITUB20152037A1 (it) Benna frantumatrice
KR102055475B9 (ko) 메시지 전송 차단 방법
EP3302710A4 (fr) Agents mobilisateurs et leurs utilisations
ITUB20152029A1 (it) Benna frantumatrice
MA40429A (fr) Gabion
HU4788U (hu) Építõelem-készlet
AU201713207S (en) Concrete Form Spacer
GB201507312D0 (en) Quantum hardened cryptosystem
IT201600131099A1 (it) Pannello fonoassorbente perfezionato.